Will FDA draw a line between other CBD products and pharmaceuticals?

The US FDA is to hold a public hearing on 31st May on the safety of products containing cannabis or cannabis-derived compounds ― and stakeholders will be looking for a dividing line ...

Restricted content. Do you want to read more?